Article Details
Retrieved on: 2025-07-08 13:10:44
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(KNSA) Stock Analysis: Exploring a 35.96% Potential Upside in Biopharma ... biopharmaceuticals. With a market cap of $2.04 billion, Kiniksa is ...
Article found on: www.directorstalkinterviews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here